Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S J Pocock

Showing results (61-70 of 138) with videos related to

Pageof 14
Sort By:
Biometrics|March 1, 1992
The impact of stopping rules on heterogeneity of results in overviews of clinical trialsM D Hughes, L S Freedman, S J Pocock
Evidence-Based Medicine|December 8, 2007
Rosiglitazone increased heart failure but did not differ from metformin plus sulphonylurea for other CV outcomes at interim analysisP D Home, S J Pocock, H Beck-Nielsen
BMJ (Clinical Research Ed.)|April 15, 1989
Concentrations of high density lipoprotein cholesterol, triglycerides, and total cholesterol in ischaemic heart diseaseS J Pocock, A G Shaper, A N Phillips
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 13, 2003
Neonatal head circumference, neonatal weight, and risk of hayfever, asthma and eczema in a large cohort of adolescents from Sheffield, EnglandK A Katz, S J Pocock, D P Strachan
Lancet (London, England)|January 6, 2000
The agonising negative trend in monitoring of clinical trialsD L DeMets, S J Pocock, D G Julian
Journal of Environmental Pathology and Toxicology|September 1, 1980
The British Regional Heart Study: cardiovascular mortality and water qualityA G Shaper, R F Packham, S J Pocock
BMJ (Clinical Research Ed.)|December 7, 1996
A comparison of aspirin and anticoagulation following thrombolysis for myocardial infarction (the AFTER study): a multicentre unblinded randomised clinical trialD G Julian, D A Chamberlain, S J Pocock
Biometrics|March 1, 1993
On the design and analysis of randomized clinical trials with multiple endpointsD I Tang, N L Geller, S J Pocock
Statistics in Medicine|October 1, 1990
Prognostic scores for detecting a high risk group: estimating the sensitivity when applied to new dataA N Phillips, S G Thompson, S J Pocock
The New England Journal of Medicine|August 13, 1987
Statistical problems in the reporting of clinical trials. A survey of three medical journalsS J Pocock, M D Hughes, R J Lee
Pageof 14

Showing results (61-70 of 138) with videos related to

Sort By:
Pageof 14
Biometrics|March 1, 1992
The impact of stopping rules on heterogeneity of results in overviews of clinical trialsM D Hughes, L S Freedman, S J Pocock
Evidence-Based Medicine|December 8, 2007
Rosiglitazone increased heart failure but did not differ from metformin plus sulphonylurea for other CV outcomes at interim analysisP D Home, S J Pocock, H Beck-Nielsen
BMJ (Clinical Research Ed.)|April 15, 1989
Concentrations of high density lipoprotein cholesterol, triglycerides, and total cholesterol in ischaemic heart diseaseS J Pocock, A G Shaper, A N Phillips
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 13, 2003
Neonatal head circumference, neonatal weight, and risk of hayfever, asthma and eczema in a large cohort of adolescents from Sheffield, EnglandK A Katz, S J Pocock, D P Strachan
Lancet (London, England)|January 6, 2000
The agonising negative trend in monitoring of clinical trialsD L DeMets, S J Pocock, D G Julian
Journal of Environmental Pathology and Toxicology|September 1, 1980
The British Regional Heart Study: cardiovascular mortality and water qualityA G Shaper, R F Packham, S J Pocock
BMJ (Clinical Research Ed.)|December 7, 1996
A comparison of aspirin and anticoagulation following thrombolysis for myocardial infarction (the AFTER study): a multicentre unblinded randomised clinical trialD G Julian, D A Chamberlain, S J Pocock
Biometrics|March 1, 1993
On the design and analysis of randomized clinical trials with multiple endpointsD I Tang, N L Geller, S J Pocock
Statistics in Medicine|October 1, 1990
Prognostic scores for detecting a high risk group: estimating the sensitivity when applied to new dataA N Phillips, S G Thompson, S J Pocock
The New England Journal of Medicine|August 13, 1987
Statistical problems in the reporting of clinical trials. A survey of three medical journalsS J Pocock, M D Hughes, R J Lee
Pageof 14